Streamlining Process Monitoring in Cell Culture Analysis & Spectrometry

Sponsored by:

Date:

August 25, 2021

Time (PT):

10:00 AM

Duration (min):

No items found.

Daniel Merriman, Femi Egbebi and Krzysztof Inglot present on research solutions offered by Thermo Fisher Scientific regarding cell culture analysis, spectrometry, and other topics within the biopharma field.

Take discovery and simple analysis to new heights. Learn about Thermo Fisher Scientific's products' BEA process monitoring capabilities - from simplifying tech transfer from research and process development into clinical trials and commercialization. This webinar aims to explain the benefits of working with the TruBio Discovery Automation System, as well as the Thermo Scientific^TM Prima PRO Process Mass Spectrometer. The newest model of the Prima PRO Process Mass Spectrometer enhances results using a variable magnetic field to maximize ion separation within the scanning magnetic sector. Gain insights on how to maximize result accuracy alongside other systemic best practices.

Who Should Attend?

Scientists interested in cell culture analysis, spectrometry, and molecule analysis

Presenters

Daniel Merriman

Thermo Fisher Scientific

Strategic Marketing Manager

Daniel Merriman joined VG Instruments, now Thermo Fisher Scientific in 1988. He has held many roles associated with online process analytics, particularly mass spectrometry, and is currently a strategic marketing manager at Thermo Fisher. During his career he has worked extensively to advance the use of online mass spectrometry as a Process Analytical Technology (PAT) in the biotechnology sector, working with industry and academia to develop applications for monitoring fermentation and cell culture processes. Daniel has recently co-authored papers with University College London and the National Institute for Bioprocess Research & Training (NIBRT) on the subject of mammalian cell culture monitoring by online mass spectrometry.

Femi Egbebi

Thermo Fisher Scientific (Media Development Services/Omics Capabilities)

Senior Global Product Manager

Femi Egbebi is the Senior Global Product Manager for Media Development Services / Omics capabilities at Bioproduction Group of Thermo Fisher Scientific. He has an MBA from Carnegie Mellon University and a PhD in Chemical Engineering from the Louisiana State University. Prior to joining Thermo Fisher in 2018, he held various technical research roles at major engineering firms.

Krzysztof Inglot

Thermo Fisher Scientific

Technical Sales Specialist

Krzysztof Inglot joined Thermo Fisher Scientific in 2017, with more than fifteen years’ experience working in the bioprocess sphere. In his current role as Technical Sales Specialist, he primarily supports single-use technologies, specializing in hardware configuration and our TruBio software. Along with his team, his experience allows Thermo Fisher to integrate different equipment and sensors from upstream and downstream areas. He has a PhD in Engineering from the Poznan University of Technology.

Thermo Fisher Scientific

Thermo Fisher Scientific is the world leader in serving science. Their mission is to enable our customers to make the world healthier, cleaner, and safer. Through our Thermo Scientific, Applied Biosystems, and Invitrogen brands. They help customers accelerate innovation and enhance productivity.

Topics

Cell Culture & Characterization

Pharmacology

Toxicology

Streamlining Process Monitoring in Cell Culture Analysis & Spectrometry

Who Should Attend?

Presenters

Daniel Merriman

Femi Egbebi

Krzysztof Inglot

Sponsor

Thermo Fisher Scientific

Topics

Watch Now

Related Content

Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Screening the Unscreenable: Expanding the Reach of Drug Discovery

Advancing the Manufacture of Mesenchymal Stromal Cells and Derived Extracellular Vesicles in Stirred-Tank Bioreactors Through Enhanced Bioprocess Control

Precision in Human Biological Samples: Leveraging Regulatory Rigor and Deep Data for Advanced Disease Research

Detecting Early Synaptic Failure in Prion Disease Using Organoid Models

Improving Preclinical Decision-Making in Obesity and CKD with Translational In Vivo Phenotyping

Bridging Mouse Models and Human Inflammatory Bowel Disease: in vivo Pharmacology, Histology and Biomarkers

Screening the Unscreenable: Expanding the Reach of Drug Discovery

High-Throughput-qPCR and Transcriptomics: Powering the Next Generation of Drug Discovery

From Clinical Data to Actionable Assets for Pharmaceutical R&D

Strategies to Optimize Commercialization of Oncology Treatments for Younger Adults

Patient Data: Opportunities for Rare Diseases, Cell and Gene Therapies, and Oncology

Trials and tribulations of drug development

Webinar Series: Early patient preferences for patient-focused drug development

Looking Beyond Survival Data: Understanding the Value of Non-OS Endpoints in Oncology Reimbursement Decision-Making

Cutting Edge Conversations: Discovering New Innovations in Oncology

Translational Success in Inflammasome Drug Discovery: How Advanced Models and Integrated Assays Can Reduce Attrition

How to Avoid Expensive Redesign Cycles in Antibody Discovery

Recent Advances in Crystalline Polymorphism Research in Drug Development

Improving Confidence in Thyroid Hormone Disruption Assessment Using a Novel Human-Relevant In Vitro Model

Accelerating Antibody Discovery: Integrating Microfluidics, HT Expression, and Early Developability Platform

Beyond Exposure: Integrating PK/PD for Translational Predictive Power

Fulfilling the Gap: Innovative Critical Reagents for Non-Human Primate Preclinical Studies

Advancing ADC Development: Leveraging AI and Translational Preclinical Models to Improve Clinical Predictability

Scaling AAV9 Manufacturing: A Blueprint for Clinical-Grade Gene Therapy Production

Human iPSC-Derived Sensory Neurons for Functional Sensory Biology and Pharmacology Research

From Biopsy to Better Decisions: Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer

Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies

Epigenomics at 360 in Liquid Biopsy: Approaches and Case Studies for Biomarker Discovery and Drug Development

The Sound of Science: Mapping the Tumor Microenvironment for Advanced Therapeutic Strategies

Next-Generation TCR-Like Antibodies With Improved Specificity Profiles

ADC Payload-Linker CMC Process Development Strategy

De-Risking Immunotherapy Targets with Next-Gen HLA Discovery Platforms

Photoreceptor Cell Therapy to Treat Advanced Retinal Degeneration

Clinical Applications of Optical Cerebral Blood Flow Imaging

ADCs on The Horizon: The Performance and Prospect of Cell Line Development Platform ‚Äî AmigoCHO

Selectivity Profiling: Unbiased Analysis of Compound Selectivity in Drug Discovery

Building New Approach Methodologies for Angiogenesis and Vascularized Models

Using ALS Patient-Derived Motor Neurons to Study TDP-43 Mislocalization

Vevo Ask The Experts: Oncology Imaging

hiPSC-Cardiomyocyte Platforms Enabling Comprehensive Cardiac Toxicity and Drug Efficacy Evaluation

Protein-Protein Interaction (PPI) Landscape - Sequence-to-Affinity Heatmaps for High-Throughput Antibody Optimization

Human Biological Samples in Research: Quality, Compliance, and Clinical Relevance

Combination Therapy for Glioblastoma: A Personalized, AI-Driven Approach

In Vivo panCAR Therapy Using Circular RNA for the Treatment of Autoimmune Disease

From Single Domain to Single B: Leveraging Biointron's Expertise for Antibody Discovery Success

Beyond Checkpoints: Strategic Use of CDX Models in Emerging IO Therapies

Non CYP Mediated Metabolism Pathways and In Vitro Evaluation Strategies

Uniting biology and digital drug discovery to identify new therapeutic opportunities in neurodegeneration

Enhance Your Tissue Processing Efficiency with the STEMprep Tissue Dissociator

Reprogramming Mouse Fibroblasts Into Induced Cardiomyocytes: Age-Related, Metabolic, and Epigenetic Barriers

Novel Applications of the Cellular Thermal Shift Assay (CETSA) Provide New Insights for Drug Discovery

Vaccine-Boosting CAR T Cells Against Solid Tumors

Exploring the iPSC-Derived Neuronal-Glia Co-culture System: A Powerful Drug Discovery Platform for Studying Neurodegenerative Diseases

Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing

Launch Event: Propelling Boundaries - Innovative Technologies in Early Drug Discovery

Advances in Preclinical Research using Human Co-culture Models: Applications in Immunology, Infectious Disease, and Oncology

Cell-Based Assays for Immuno-oncology

Artificial Intelligence in Preclinical Research: Pathology, Biospecimens, and Model Selection

CAR Finder - A Platform for Rapid CAR T Cell Screening

CRISPR Gene Editing in Primary T Cells: A Case Study in the Fight Against HIV

Improved Clearance Predictions for Aldehyde Oxidase Substrates Using TruVivo, a Novel Human Hepatocyte Model

Introduction to Bispecific Antibodies and Their Production

The Hidden Variable in Your Intestinal Organoids: Enhancing Differentiation for a More Predictive Model

Integrating Functionalized Multi-omics in Oncology Drug Discovery

Fresh or Cryopreserved Leukopaks? Assessing the Impact of Different Storage Conditions on Leukopak Stability

Breaking the Bottleneck: Harnessing Proteomics Services to Overcome Challenges in Clinical Research

Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI